EXTH-06. CD38-TARGETED THERAPY IN GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM) remains a malignancy with a dismal prognosis in spite of current optimal management, including maximal resection, radiation therapy, and alkylating chemotherapy. Relapse is inevitable with the paucity of further effective therapies. The development of novel targeted th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Aulakh, Sonikpreet, Manna, Alak, Schiapparelli, Paula, Ailawadhi, Sikander, Paulus, Aneel, Rosenfeld, Steven, Quinones-Hinojosa, Alfredo, Chanan-Khan, Asher
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Abstracts
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216983/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.355
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia